Literature DB >> 4031030

Simplified bioassay method for measurement of flucytosine or ketoconazole.

C A Bodet, J H Jorgensen, D J Drutz.   

Abstract

A simple agar-well diffusion bioassay suitable for measurement of flucytosine or ketoconazole was developed by using Candida pseudotropicalis ATCC 46764 as the assay organism. A test medium composed of (per liter) 7 g of Trypticase peptone, 7 g of YNB (yeast-nitrogen base), 15 g of glucose, and 15 g of agar was seeded with an inoculum which had been grown to no. 2 McFarland turbidity after 4 to 6 h in YNB-glucose broth. Determinations of flucytosine or ketoconazole were performed without necessity of heating or diluting of serum samples to alleviate amphotericin B interference. A linear relationship between zone diameters and log10 concentration of the drugs was observed over the pharmacologically relevant ranges of 25 to 160 micrograms/ml for flucytosine and 0.5 to 20 micrograms/ml for ketoconazole. The mean coefficient of variability for samples measured on 5 separate days was 2.4% for flucytosin and 4.0% for ketoconazole. This assay represents a significant improvement over previous bioassay methods in that a single test system may be used for measurement of either flucytosine or ketoconazole, no serum dilution or pretreatment is required, inoculum preparation is accomplished entirely on the day of the assay, and sharp, clearly defined zones of inhibition are obtained with both drugs.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4031030      PMCID: PMC268350          DOI: 10.1128/jcm.22.2.157-160.1985

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  17 in total

1.  Rapid determination of serum 5-fluorocytosine levels by high-performance liquid chromatography.

Authors:  R B Diasio; M E Wilburn; S Shadomy; A Espinel-Ingroff
Journal:  Antimicrob Agents Chemother       Date:  1978-03       Impact factor: 5.191

2.  A comparison of amphotericin B alone and combined with flucytosine in the treatment of cryptoccal meningitis.

Authors:  J E Bennett; W E Dismukes; R J Duma; G Medoff; M A Sande; H Gallis; J Leonard; B T Fields; M Bradshaw; H Haywood; Z A McGee; T R Cate; C G Cobbs; J F Warner; D W Alling
Journal:  N Engl J Med       Date:  1979-07-19       Impact factor: 91.245

3.  Liquid chromatographic assay of ketoconazole.

Authors:  F A Andrews; L R Peterson; W H Beggs; D Crankshaw; G A Sarosi
Journal:  Antimicrob Agents Chemother       Date:  1981-01       Impact factor: 5.191

4.  Evidence for conversion of 5-fluorocytosine to 5-fluorouracil in humans: possible factor in 5-fluorocytosine clinical toxicity.

Authors:  R B Diasio; D E Lakings; J E Bennett
Journal:  Antimicrob Agents Chemother       Date:  1978-12       Impact factor: 5.191

5.  Pharmacological studies with 5-fluorocytosine.

Authors:  E R Block; J E Bennett
Journal:  Antimicrob Agents Chemother       Date:  1972-06       Impact factor: 5.191

6.  Ketoconazole treatment of chronic mucocutaneous candidiasis.

Authors:  J R Graybill; J H Herndon; W T Kniker; H B Levine
Journal:  Arch Dermatol       Date:  1980-10

7.  Simple assay for 5-fluorocytosine in the presence of amphotericin B.

Authors:  C A Kauffman; J A Carleton; P T Frame
Journal:  Antimicrob Agents Chemother       Date:  1976-03       Impact factor: 5.191

8.  Ketoconazole in griseofulvin-resistant dermatophytosis.

Authors:  M H Robertson; P Rich; F Parker; J M Hanifin
Journal:  J Am Acad Dermatol       Date:  1982-02       Impact factor: 11.527

9.  Bone marrow toxicity associated with 5-fluorocytosine therapy.

Authors:  C A Kauffman; P T Frame
Journal:  Antimicrob Agents Chemother       Date:  1977-02       Impact factor: 5.191

10.  Sensitive bioassay for ketoconazole in serum and cerebrospinal fluid.

Authors:  J H Jorgensen; G A Alexander; J R Graybill; D J Drutz
Journal:  Antimicrob Agents Chemother       Date:  1981-07       Impact factor: 5.191

View more
  16 in total

1.  High-dose itraconazole in the treatment of severe mycoses.

Authors:  P K Sharkey; M G Rinaldi; J F Dunn; T C Hardin; R J Fetchick; J R Graybill
Journal:  Antimicrob Agents Chemother       Date:  1991-04       Impact factor: 5.191

2.  Standardization of a fluconazole bioassay and correlation of results with those obtained by high-pressure liquid chromatography.

Authors:  J H Rex; L H Hanson; M A Amantea; D A Stevens; J E Bennett
Journal:  Antimicrob Agents Chemother       Date:  1991-05       Impact factor: 5.191

3.  Systemic availability of itraconazole in lung transplantation.

Authors:  T F Patterson; J Peters; S M Levine; A Anzueto; C L Bryan; E Y Sako; O L Miller; J H Calhoon; M G Rinaldi
Journal:  Antimicrob Agents Chemother       Date:  1996-09       Impact factor: 5.191

4.  Antifungal therapy in a murine model of disseminated infection by Cryptococcus gattii.

Authors:  Enrique Calvo; F Javier Pastor; M Mar Rodríguez; Isabel Pujol; Josep Guarro
Journal:  Antimicrob Agents Chemother       Date:  2010-07-12       Impact factor: 5.191

5.  Combined therapy with fluconazole and flucytosine in murine cryptococcal meningitis.

Authors:  R Allendoerfer; A J Marquis; M G Rinaldi; J R Graybill
Journal:  Antimicrob Agents Chemother       Date:  1991-04       Impact factor: 5.191

6.  Murine model of a disseminated infection by the novel fungus Fonsecaea monophora and successful treatment with posaconazole.

Authors:  Enrique Calvo; F Javier Pastor; M Mar Rodríguez; Emilio Mayayo; Valentina Salas; Josep Guarro
Journal:  Antimicrob Agents Chemother       Date:  2009-12-14       Impact factor: 5.191

Review 7.  Clinical pharmacokinetics of fluconazole.

Authors:  D Debruyne; J P Ryckelynck
Journal:  Clin Pharmacokinet       Date:  1993-01       Impact factor: 6.447

8.  Evaluation of SCH51048 in an experimental model of pulmonary aspergillosis.

Authors:  R Allendoerfer; D Loebenberg; M G Rinaldi; J R Graybill
Journal:  Antimicrob Agents Chemother       Date:  1995-06       Impact factor: 5.191

Review 9.  Clinical pharmacokinetics of ketoconazole.

Authors:  T K Daneshmend; D W Warnock
Journal:  Clin Pharmacokinet       Date:  1988-01       Impact factor: 6.447

10.  Efficacy of itraconazole solution in a rabbit model of invasive aspergillosis.

Authors:  T F Patterson; A W Fothergill; M G Rinaldi
Journal:  Antimicrob Agents Chemother       Date:  1993-11       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.